AbCellera nabs Series B led by OrbiMed and DCVC Bio
Vancouver, British Columbia-based AbCellera, a biotech company, has raised US$105 million in Series B financing.
Vancouver, British Columbia-based AbCellera, a biotech company, has raised US$105 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination